 | Given the vast amount of misinformation presented in the consumer media regarding cosmetic treatments, In The Know presents patients with information grounded in medicine and coming from the real experts. We talk with dermatologists and cosmetic surgeons on topics ranging from rosacea and acne, to fillers, lasers and facelifts. We hope the topics educate patients, inspire them to ask questions, and maybe even spur them to try a procedure. To read our content, click here. |  |
| | | | MacroChem announces phase 2 data for EcoNail in treatment of onychomychosis
Jul 24, 2008 New York — MacroChem Corporation announces results of a phase 2 clinical trial of EcoNail,a topical antifungal for the treatment of onychomychosis, according to Earthtimes.org. | | Melanoma rates rise in younger women
Jul 14, 2008 National report — The rate of melanoma cases in younger women has increased 50 percent since 1980, but did not increase in younger men, according to a study published in the Journal of Investigative Dermatology. | | UV light therapy as beneficial for darker skin as lighter skin
Jul 9, 2008 Dallas — An analysis of more than 100 patients shows that darker-skinned patients benefit from light therapy to treat morphea and related diseases as much as lighter-skinned patients, according to ScienceDaily. | | Etanercept demonstrates therapeutic effect on keloids
Jul 8, 2008 National report — A study shows that intralesional etanercept may provide an effective treatment for keloids, according to TherapeuticsDaily. | |
| More Articles |
| | | |
 |  | In this month’s Special Report, Dermatology Times looks at the the unique concerns of ethnic patients, including the skin conditions and cultural issues dermatologists should consider when treating blacks, Hispanics and Asian Americans. Blacks, for instance, often are diagnosed with melanoma at a later stage than are Caucasians.
To read our content, click here. |
| Brain drain: Dermatologists shunning, leaving academia
| | While schools known for academic dermatology produce and retain a relatively high proportion of academic dermatologists, the career path on the whole suffers from low interest among recent graduates — and high attrition rates over time, experts say.  |
| | |
|